<unk>  is an atypical antipsychotic drug indicated for acute and chronic schizophrenia. It has been used in Germany since 1990 (although it has been discontinued in Germany) and Japan since 1982.<unk>  is not approved for use in the United States, United Kingdom, Australia, Canada or New Zealand.
Zotepine
Dezocine
Midazolam
Remimazolam
Cidoxepin
Mexazolam
Ketazolam
Propizepine